Company e-therapeutics plc London S.E.
Equities
ETX
GB00B2823H99
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9 GBX | -6.74% | -.--% | +9.22% |
Business Summary
Number of employees: 34
Sales per Business
GBP in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
Drug Discovery
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -33.05% |
Sales per region
GBP in Million | 2023 | Weight | 2024 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -33.05% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 584,335,487 | 174,957,350 ( 29.94 %) | 0 | 29.94 % |
Company contact information
e-Therapeutics Plc
Paddington Central 4 Kingdom Street
W2 6BD, London
+44 20 4551 8888
http://www.etherapeutics.co.ukSector
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- ETXPF Stock
- ETX Stock
- Company e-therapeutics plc